Selected research
Market Structure
Global Sodium Iodine (131I) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sodium Iodine (131I) Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sodium Iodine (131I) Drugs include Hta Co., Ltd, Yantai Dongcheng Biochemicals Co.,Ltd., Chengdu Gaotong Isotope Co.,Ltd., Mallinckrodt, Jubilant Radiopharma, International Isotopes, BWXT Medical Ltd, Bracco and AnazaoHealth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sodium Iodine (131I) Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sodium Iodine (131I) Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sodium Iodine (131I) Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sodium Iodine (131I) Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Sodium Iodine (131I) Drugs Segment by Company
Hta Co., Ltd
Yantai Dongcheng Biochemicals Co.,Ltd.
Chengdu Gaotong Isotope Co.,Ltd.
Mallinckrodt
Jubilant Radiopharma
International Isotopes
BWXT Medical Ltd
Bracco
AnazaoHealth
Sodium Iodine (131I) Drugs Segment by Type
Sodium Iodine [131I] Capsules
Sodium iodine [131I] Oral Solution
Sodium Iodine (131I) Drugs Segment by Application
Diagnosis and Investigation
Thyroid Cancer
Hyperthyroidism
Sodium Iodine (131I) Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Iodine (131I) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Iodine (131I) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Iodine (131I) Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sodium Iodine (131I) Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sodium Iodine (131I) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sodium Iodine (131I) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sodium Iodine (131I) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Sodium Iodine [131I] Capsules
- Sodium iodine [131I] Oral Solution
Applications
- Diagnosis and Investigation
- Thyroid Cancer
- Hyperthyroidism
Companies covered
- Hta Co., Ltd
- Yantai Dongcheng Biochemicals Co.,Ltd.
- Chengdu Gaotong Isotope Co.,Ltd.
- Mallinckrodt
- Jubilant Radiopharma
- International Isotopes
- BWXT Medical Ltd
- Bracco
- AnazaoHealth
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sodium Iodine (131I) Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sodium Iodine (131I) Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sodium Iodine (131I) Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sodium Iodine (131I) Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sodium Iodine (131I) Drugs Market Dynamics
- 2.1 Sodium Iodine (131I) Drugs Industry Trends
- 2.2 Sodium Iodine (131I) Drugs Industry Drivers
- 2.3 Sodium Iodine (131I) Drugs Industry Opportunities and Challenges
- 2.4 Sodium Iodine (131I) Drugs Industry Restraints
3 Sodium Iodine (131I) Drugs Market by Manufacturers
- 3.1 Global Sodium Iodine (131I) Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Sodium Iodine (131I) Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Sodium Iodine (131I) Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sodium Iodine (131I) Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sodium Iodine (131I) Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sodium Iodine (131I) Drugs Manufacturers, Product Type & Application
- 3.7 Global Sodium Iodine (131I) Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sodium Iodine (131I) Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sodium Iodine (131I) Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Sodium Iodine (131I) Drugs Tier 1, Tier 2, and Tier 3
4 Sodium Iodine (131I) Drugs Market by Type
- 4.1 Sodium Iodine (131I) Drugs Type Introduction
- 4.1.1 Sodium Iodine [131I] Capsules
- 4.1.2 Sodium iodine [131I] Oral Solution
- 4.2 Global Sodium Iodine (131I) Drugs Sales by Type
- 4.2.1 Global Sodium Iodine (131I) Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sodium Iodine (131I) Drugs Sales by Type (2021-2032)
- 4.2.3 Global Sodium Iodine (131I) Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Sodium Iodine (131I) Drugs Revenue by Type
- 4.3.1 Global Sodium Iodine (131I) Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sodium Iodine (131I) Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Sodium Iodine (131I) Drugs Revenue Market Share by Type (2021-2032)
5 Sodium Iodine (131I) Drugs Market by Application
- 5.1 Sodium Iodine (131I) Drugs Application Introduction
- 5.1.1 Diagnosis and Investigation
- 5.1.2 Thyroid Cancer
- 5.1.3 Hyperthyroidism
- 5.2 Global Sodium Iodine (131I) Drugs Sales by Application
- 5.2.1 Global Sodium Iodine (131I) Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sodium Iodine (131I) Drugs Sales by Application (2021-2032)
- 5.2.3 Global Sodium Iodine (131I) Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Sodium Iodine (131I) Drugs Revenue by Application
- 5.3.1 Global Sodium Iodine (131I) Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sodium Iodine (131I) Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Sodium Iodine (131I) Drugs Revenue Market Share by Application (2021-2032)
6 Global Sodium Iodine (131I) Drugs Sales by Region
- 6.1 Global Sodium Iodine (131I) Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sodium Iodine (131I) Drugs Sales by Region (2021-2032)
- 6.2.1 Global Sodium Iodine (131I) Drugs Sales by Region (2021-2026)
- 6.2.2 Global Sodium Iodine (131I) Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sodium Iodine (131I) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sodium Iodine (131I) Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sodium Iodine (131I) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sodium Iodine (131I) Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sodium Iodine (131I) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sodium Iodine (131I) Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sodium Iodine (131I) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sodium Iodine (131I) Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sodium Iodine (131I) Drugs Revenue by Region
- 7.1 Global Sodium Iodine (131I) Drugs Revenue by Region
- 7.1.1 Global Sodium Iodine (131I) Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sodium Iodine (131I) Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Sodium Iodine (131I) Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Sodium Iodine (131I) Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sodium Iodine (131I) Drugs Revenue (2021-2032)
- 7.2.2 North America Sodium Iodine (131I) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sodium Iodine (131I) Drugs Revenue (2021-2032)
- 7.3.2 Europe Sodium Iodine (131I) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sodium Iodine (131I) Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sodium Iodine (131I) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sodium Iodine (131I) Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sodium Iodine (131I) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Hta Co., Ltd
- 8.1.1 Hta Co., Ltd Company Information
- 8.1.2 Hta Co., Ltd Business Overview
- 8.1.3 Hta Co., Ltd Sodium Iodine (131I) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Hta Co., Ltd Sodium Iodine (131I) Drugs Product Portfolio
- 8.1.5 Hta Co., Ltd Recent Developments
- 8.2 Yantai Dongcheng Biochemicals Co.,Ltd.
- 8.2.1 Yantai Dongcheng Biochemicals Co.,Ltd. Company Information
- 8.2.2 Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview
- 8.2.3 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
- 8.2.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments
- 8.3 Chengdu Gaotong Isotope Co.,Ltd.
- 8.3.1 Chengdu Gaotong Isotope Co.,Ltd. Company Information
- 8.3.2 Chengdu Gaotong Isotope Co.,Ltd. Business Overview
- 8.3.3 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
- 8.3.5 Chengdu Gaotong Isotope Co.,Ltd. Recent Developments
- 8.4 Mallinckrodt
- 8.4.1 Mallinckrodt Company Information
- 8.4.2 Mallinckrodt Business Overview
- 8.4.3 Mallinckrodt Sodium Iodine (131I) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Mallinckrodt Sodium Iodine (131I) Drugs Product Portfolio
- 8.4.5 Mallinckrodt Recent Developments
- 8.5 Jubilant Radiopharma
- 8.5.1 Jubilant Radiopharma Company Information
- 8.5.2 Jubilant Radiopharma Business Overview
- 8.5.3 Jubilant Radiopharma Sodium Iodine (131I) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Jubilant Radiopharma Sodium Iodine (131I) Drugs Product Portfolio
- 8.5.5 Jubilant Radiopharma Recent Developments
- 8.6 International Isotopes
- 8.6.1 International Isotopes Company Information
- 8.6.2 International Isotopes Business Overview
- 8.6.3 International Isotopes Sodium Iodine (131I) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 International Isotopes Sodium Iodine (131I) Drugs Product Portfolio
- 8.6.5 International Isotopes Recent Developments
- 8.7 BWXT Medical Ltd
- 8.7.1 BWXT Medical Ltd Company Information
- 8.7.2 BWXT Medical Ltd Business Overview
- 8.7.3 BWXT Medical Ltd Sodium Iodine (131I) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 BWXT Medical Ltd Sodium Iodine (131I) Drugs Product Portfolio
- 8.7.5 BWXT Medical Ltd Recent Developments
- 8.8 Bracco
- 8.8.1 Bracco Company Information
- 8.8.2 Bracco Business Overview
- 8.8.3 Bracco Sodium Iodine (131I) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Bracco Sodium Iodine (131I) Drugs Product Portfolio
- 8.8.5 Bracco Recent Developments
- 8.9 AnazaoHealth
- 8.9.1 AnazaoHealth Company Information
- 8.9.2 AnazaoHealth Business Overview
- 8.9.3 AnazaoHealth Sodium Iodine (131I) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 AnazaoHealth Sodium Iodine (131I) Drugs Product Portfolio
- 8.9.5 AnazaoHealth Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sodium Iodine (131I) Drugs Value Chain Analysis
- 9.1.1 Sodium Iodine (131I) Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sodium Iodine (131I) Drugs Production Mode & Process
- 9.2 Sodium Iodine (131I) Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sodium Iodine (131I) Drugs Distributors
- 9.2.3 Sodium Iodine (131I) Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst